| __timestamp | Agios Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 79838000 |
| Thursday, January 1, 2015 | 141827000 | 121816000 |
| Friday, January 1, 2016 | 220163000 | 117633000 |
| Sunday, January 1, 2017 | 292681000 | 4577000 |
| Monday, January 1, 2018 | 1397000 | 12670000 |
| Tuesday, January 1, 2019 | 1317000 | 12135000 |
| Wednesday, January 1, 2020 | 2805000 | 18942000 |
| Friday, January 1, 2021 | 18777000 | 32328000 |
| Saturday, January 1, 2022 | 1704000 | 44678000 |
| Sunday, January 1, 2023 | 9504000 | 65486000 |
| Monday, January 1, 2024 | 4165000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. This analysis delves into the cost of revenue trends for PTC Therapeutics, Inc. and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this decade, Agios Pharmaceuticals experienced a significant fluctuation, with costs peaking in 2017, reaching nearly 300% of their 2014 levels, before plummeting to a mere fraction in subsequent years. In contrast, PTC Therapeutics showcased a more stable trajectory, with costs gradually increasing by approximately 18% annually, peaking in 2023. This divergence highlights Agios's strategic shifts and PTC's steady growth. Such insights are crucial for investors and stakeholders aiming to navigate the complexities of the biotech sector. As the industry continues to innovate, understanding these financial underpinnings will be key to making informed decisions.
Cost Insights: Breaking Down Eli Lilly and Company and PTC Therapeutics, Inc.'s Expenses
Novartis AG vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and PTC Therapeutics, Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Agios Pharmaceuticals, Inc.
Bio-Techne Corporation vs Agios Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Catalent, Inc. and PTC Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: PTC Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored